<table><tr><td>Sanjay Kapoor</td><td>Chairman</td><td>Independent Director</td></tr><tr><td>Avinash Rai</td><td>Member</td><td>Independent Director</td></tr><tr><td>Gurpreet Kaur</td><td>Member</td><td>Independent Director</td></tr></table>

Our Company Secretary and Compliance officer will act as the secretary of the Committee.

The scope, functions, and the terms of reference of the Nomination and Remuneration Committee is in accordance with the Section 178 of the Companies Act, 2013 read with Regulation 19 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The terms of reference of Nomination and Remuneration Committee shall include the following:

1. Formulation of the criteria for determining qualifications, positive attributes and independence of a director and recommend to the Board of Directors a policy relating to, the remuneration of the directors, Key Managerial Personnel and other employees.

(1A). For every appointment of an independent director, the Nomination and Remuneration Committee shall evaluate the balance of skills, knowledge and experience on the Board and on the basis of such evaluation, prepare a description of the role and capabilities required of an independent director. The person recommended to the Board for appointment as an independent director shall have the capabilities identified in such description. For the purpose of identifying suitable candidates, the Committee may:

a. use the services of an external agencies, if required;

b. consider candidates from a wide range of backgrounds, having due regard to diversity; and

c. consider the time commitments of the candidates.

2. Formulation of criteria for evaluation of performance of Independent Directors and the Board of Directors.

3. Devising a policy on diversity of Board of Directors.

4. Identifying persons who are qualified to become directors and who may be appointed in senior management in accordance with the criteria laid down, and recommend to the Board of Directors their appointment and removal.

5. Whether to extend or continue the term of appointment of the Independent Director, on the basis of the report of performance evaluation of Independent Directors.

6. recommend to the board, all remuneration, in whatever form, payable to senior management.

7. Such other matters as may from time to time be required by any statutory, contractual or other regulatory requirements to be attended to by such committee.

The Nomination and Remuneration Committee is required to meet at least once in a financial year under Regulation 19(3A) of the SEBI Listing Regulations.

The quorum for a meeting of the Nomination and Remuneration Committee shall be two members or one third of the members of the committee, whichever is greater, including at least one independent director.

## Stakeholder's Relationship Committee

The Stakeholder's Relationship Committee was reconstituted at a meeting of the Board of Directors held on June 12, 2025, As on the date of this Draft Red Herring Prospectus the Stakeholder's Relationship Committee comprises of:

<table><thead><tr><td>Sr. No.</td><td>Names of Member</td><td>Designation in Board</td><td>Designation in Committee</td></tr></thead><tbody><tr><td>1</td><td>Sanjay Kapoor</td><td>Independent Non-Executive Director</td><td>Chairman</td></tr><tr><td>2</td><td>Chirag Gupta</td><td>Executive Director</td><td>Member</td></tr><tr><td>3</td><td>Piyush Gupta</td><td>Executive Director</td><td>Member</td></tr></tbody></table>

a. The role of Stakeholder Relationship Committee, together with its powers, is as follows:

b. Allotment and listing of our shares in future

c. Redressing of shareholders and investor complaints such as non-receipt of declared dividend, annual report, transfer of Equity Shares and issue of duplicate/split/consolidated share certificates;

d. Monitoring transfers, transmissions, dematerialization, re-materialization, splitting and consolidation of Equity Shares and other securities issued by our Company, including review of cases for refusal of transfer/ transmission of shares and debentures;

e. Reference to statutory and regulatory authorities regarding investor grievances;

f. To otherwise ensure proper and timely attendance and redressal of investor queries and grievances;

170